Persistent neuroinvasive west nile virus infection in an immunocompromised patient

Clinical Infectious Diseases

Volumn 42, Issue 5, 2006, Pages 680-683

  Penn, Robert G ^a,b   Guarner, Jeannette ^c,e   Sejvar, James J ^c,d   Hartman, Herbert ^b   McComb, Rodney D ^b   Nevins, Diana L ^b   Bhatnagar, Julu ^c   Zaki, Sherif R ^c  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; MITOXANTRONE; PREDNISONE; RIBAVIRIN; VINCRISTINE; VIRUS ANTIBODY; VIRUS ANTIGEN; VIRUS RNA;

ADULT; ARTHRALGIA; ARTICLE; AUTOPSY; B CELL LYMPHOMA; CASE REPORT; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; COMPUTER ASSISTED TOMOGRAPHY; CUSHINGOID SYNDROME; DISORIENTATION; DYSARTHRIA; DYSMETRIA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEVER; FOLLICULAR LYMPHOMA; HOSPITALIZATION; HUMAN; HUMAN TISSUE; IMMUNE DEFICIENCY; IMMUNOHISTOCHEMISTRY; MALE; MENINGOENCEPHALITIS; MYALGIA; MYOCLONUS; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; SERUM; TACHYCARDIA; TREMOR; VIRUS TRANSMISSION; WEAKNESS; WEST NILE FLAVIVIRUS;

ANTIGENS, VIRAL; FATAL OUTCOME; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOGLOBULINS; MALE; MIDDLE AGED; RNA, VIRAL; WEST NILE FEVER;

EID: 33144458602     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/500216     Document Type: Article

References (15)

1. Sejvar JJ, Haddad MB, Tierney BC, et al. Neurologic manifestations and outcome of West Nile virus infection. JAMA 2003;290:511-5.
2. Petersen LR, Roehrig JT, Hughes JM. West Nile virus encephalitis. N Engl J Med 2002; 347:1225-6.
3. Chowers MY, Lang R, Nassar F, et al. Clinical characteristics of the West Nile fever outbreak, Israel, 2000. Emerg Infect Dis 2001; 7:675-8.
4. Okazaki H. Fundamentals of neuropathology, morphologic basis of neurologic disorders. 2nd ed. New York: Igaku-Shoin Medical Publishers, 1989:131-44.
5. Huang C, Slater B, Rudd R, et al. First isolation of West Nile virus from a patient with encephalitis in the United States. Emerg Infect Dis 2002; 8:1367-71.
6. Kleinschmidt-DeMasters BK, Marder BA, Levi ME, et al. West Nile virus encephalomyelitis in transplant recipients. JAMA 2004; 292:859-60.
7. Guarner J, Shieh WJ, Hunter S, et al. Clinicopathologic study and laboratory diagnosis of 23 cases with West Nile virus encephalomyelitis. Hum Pathol 2004; 35:983-90.
8. Shi PY, Kauffman EB, Ren P, et al. High-throughput detection of West Nile virus RNA. J Clin Microbiol 2001; 39:1264-71.
9. National Institutes of Health. Basic local alignment search tool (BLAST). Available at: http://www.ncbi.nlm.nih.gov:80?BLAST/. Accessed 17 May 2004.
10. Pogodina W, Frolova MP, Malenko GI, et al. Study on West Nile virus persistence in monkeys. Arch Virol 1983; 75:71-86.
11. Deubel V, Fiette L, Gounoun P, et al. Variations in biological features of West Nile viruses. Ann N Y Acad Sci 2001; 951:195-206.
12. Lanciotti RS, Kerst AJ, Nasci RS, et al. Rapid detection of West Nile virus from human clinical specimens, field-collected mosquitoes, and avian samples by a TaqMan reverse transcriptase PCR assay. J Clin Microbiol 2000; 38:4066-71.
13. Martin DA, Noga A, Kosoy O, Johnson AJ, Petersen LR, Lanciotti RS. Evaluation of a diagnostic algorithm using immunoglobulin M enzyme-linked immunosorbent assay to differentiate human West Nile virus and St. Louis encephalitis virus infections during the 2002 West Nile virus epidemic in the United States. Clin Diagn Lab Immunol 2004; 11:1130-3.
14. Ramakrisha C, Bergmann C, Atkinson R, Stohlman S. Control of central nervous system viral persistence by neutralizing antibody. J Virol 2003; 77:4670-8.
15. Ben-Nathan D, Lustig S, Tam G, Robinzon S, Segal S, Rager-Zisman B. Prophylactic and therapeutic efficacy of human intravenous immunoglobulin in treating West Nile virus infection in mice. J Infect Dis 2003; 188:5-12.